Brilinta
Manufacturing · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Ontario, CanadaWebsite
www.brilinta.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Brilinta
For at least the first 12 months following ACS, it is superior to clopidogrel. BRILINTA also reduces the rate of stent thrombosis in patients who have been stented for treatment of ACS. Take some time and explore more information about the: Pharmacology of BRILINTA Clinical efficacy and safety of BRILINTA for both the PLATO* trial and PEGASUS trial Safety profile for BRILINTA, including bleeding and other adverse events from the clinical trials Learn more about the pharmacology of BRILINTAExplore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Brilinta your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Brilinta has recently received funding, and reach out quickly before it becomes old news!
Check out if Brilinta is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Brilinta
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Brilinta recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Brilinta has new funding data
Click to see if Brilinta had a recent Job posting/layoffs
Brilinta, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Brilinta launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to Brilinta
Compare insights from companies similar to Brilinta, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Brilinta
<$5M
1-10
Private
-
-
N/A
Company Profile Activity
Activity Insights
Brilinta is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Brilinta is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Brilinta.
Brilinta Tech Stack
A closer look at the technologies used by Brilinta
Brilinta News & Media
The Landmark DECLARE-TIMI 58 Cardiovascular Outcomes Trial of FARXIGA in Patients with Type 2 Diabetes to Be Featured at AHA 2018
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca will present 20 abstracts including a late-breaking oral presentation on the full results from the Phase III cardiovascular (CV) outcomes trial (CVOT) DECLARE (Dapagliflozin Effect on Cardiovascular Events)-TIMI 58, the broadest SGLT2 inhibitor CVOT conducted to date, as well as new research from the Company’s Cardiovascular, Renal & Metabolism (CVMD) therapy area at the American Heart Association (AHA) Scientific Sessions, November 10-12, 2018Brilinta 2016-2017 U.S Promotional Report - Research and Markets
DUBLIN--(BUSINESS WIRE)--The "Brilinta 2016 U.S Promotional Report" report has been added to Research and Markets' offering. The 5 Key Questions Addressed by this Report: How many physicians were reached by Brilinta through personal promotion in 2016 and how does this compare to its peer set in the Stroke Prevention markets? What promotional mix was leveraged (e.g., sales rep detailing, physician education, and paid speaking) and what was the median spend on each type of activity?
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Brilinta
Sign Up For FreeTo access detailed company insights
For at least the first 12 months following ACS, it is superior to clopidogrel. BRILINTA also reduces the rate of stent thrombosis in patients who have been stented for treatment of ACS. Take some time and explore more information about the: Pharmacology of BRILINTA Clinical efficacy and safety of BRILINTA for both the PLATO* trial and PEGASUS trial... Read More
